Dr Tess Lawrie (foto YouTube)
Ivermectin Evidence with Dr Tess Lawrie
Thank you very much Dr Lawrie
Ivermectin Interview, Dr Tess Lawrie
Ivermectin reduces the Risk of Death from COVID 19. A rapid Review and Meta Analysis in Support of the Recommendation of the Front Line COVID 19 Critical Care Alliance
Kory P, Meduri GU, Iglesias J, et al. Review of the Emerging Evidence demonstrating the Eficacy of Ivermectin in the Prophylaxis and Treatment of COVID 19. 18 December 2020.
World Health Organization. 21st Model List of Essential Medicines. Geneva, Switzerland. 2019.
Higgins, JPT, Thomas, J, Chandler, J, Cumpsto,n M, Li, T, Page, MJ, Welch ,VA (Editors), Cochrane Handbook for Systematic Reviews of Interventions, Version 6.0, Cochrane, 2019.
The GRADE Working Group. GRADE, 2020.
Alam, MT, Murshed R, Gomes, PF, Masud, ZM, Saber, S, Chaklader, MA, Khanam, F, Hossain, M, Momen, ABIM, Yasmin, N, Alam, RF, Sultana, A, Robin, RC, Ivermectin as Pre Exposure Prophylaxis for COVID 19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka | An Observational Studyhttps://ejmed.org/index.php/ejmed/article/view/599
Elgazzar, A, Eltaweel, A, Youssef, SA, Hany B, Hafez, M and Moussa, H, Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID 19 Pandemic, Research Square, 28 December 2020
Chowdhury, ATMM, Shahbaz, M, Karim, MR, Islam, J, Guo, D, and He, SA, Randomized Trial of Ivermectin Doxycycline and Hydroxychloroquine Azithromycin Therapy on COVID19 Patient
Podder, CS, Chowdhury, N, Mohim, IS and Haque, W, (2020). Outcome of Ivermectin treated mild to moderate COVID 19 Cases: a Single Centre, Open Label, Randomised Controlled Study, IMC Journal of Medical Science.
Niaee, MS, Gheib, N, Namdar, P, Allami, A, Zolghad, L, Javadi, A, et al, Ivermectin as an Adjunct Treatment for Hospitalized Adult COVID 19 Patients: A Randomized Multi Centre Clinical Trial, Research Square, 24 November 2020
Hashim HA, Maulood MF, Rasheed AM, Fatak DF, Kabah KK, Abdulami AS, et al. Controlled Randomized Clinical Trial on using Ivermectin with Doxycycline for treating COVID 19 Patients in Baghdad, Iraq, medRxiv, 2020.10.26.2021934
Ahmed S, Karim, MM, Ross, AG, Hossain MS, Clemens, JD, Sumiya, MK, et al. A Five Day Course of Ivermectin for the Treatment of COVID 19 may reduce the Duration of Illnes, Int. J Infectious Disease, 2 December 2020.
Chachar, AZK, Khan, KA, Asif, M, Tanveer, K, Khaqan, A and Basri, R. Effectiveness of Ivermectin in SARS-CoV 2 | COVID 19 Patients, International Journal of Sciences November 2020, 31 V1.2, 6th January 2021, 20 35
Cepelowicz Rajter, J, Sherman, MS, Fatteh, N, Vogel, F, Sacks, J and Rajter, JJ. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Corona Virus Disease 2019. J. Chest [Internet] 27Oct.2020.
Khan, SI, Khan, SI, Debnath, CR, Nath, PN, Al, Mahtab M, Nabeka, H, et al., Ivermectin Treatment May Improve the Prognosis of Patients With COVID 19,Archivos de Bronconeumología, 2020. Volume 56, Issue 12, Pages 828 – 830, ISSN 0300 2896, Spain.
Gorial FI, Mashhadani S, Sayaly HM, Dakhil BD, AlMashhadani MM, Aljabory AM, et al. Effectiveness of Ivermectin as Add On Therapy in COVID19 Management, Pilot Trial, MedRxiv, July 7 2020., 20145979.
Spoorthi, V, Sasank, S, Utility of ivermectin and Doxycycline Combination for the Treatment of SARS CoV 2, International Archives of Integrated Medicine.